tickrz reports
  
tickrz rank
A
Cigna Corp (CI)
Healthcare | Health Care Plans
CEO: David Michael Cordani
Employees: 39300
cigna.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank80Dividend Rank267
Moat Rank185Financial Strength Rank269
Growth Rank69Momentum Rank138
DIVIDEND ANALYSIS
Dividend Yield0.02%
Payout RatioN/A
3 yr Dividend Growth0%
VALUATION RATIOS
P/E Ratio21.2x
P/B Ratio2.9x
P/S Ratio1.03x
EV/EBITDA Ratio4.46x
FINANCIAL STRENGTH
Piotroski F-ScoreNOT AVAILABLE
Debt-to-Equity32%
Interest Coverage0x
MOAT
ROE14.21%
ROIC0%
Net Margin4.7%
GROWTH
5 yr EPS Growth8.24%
5 yr SPS Growth12.54%
5 yr BPS Growth12.81%
tickrz A-Ranked Cigna Corp scores well on valuation and momentum
 tickrz summary
Cigna Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cigna Corp's valuation score is comprised of a P/E ratio of 21.2x, a P/B ratio of 2.9x, a P/S ratio of 1x, and an EV/EBITDA ratio of 4.5x. Cigna Corp ranks 80 out of the S&P 500 constituents on valuation--a relatively strong score.Cigna Corp ranks 15 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cigna Corp warrants further investigation.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages. Interest coverage of 0x, a debt/equity ratio of 32% and a Moat Rank of 185 translate to an average Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 21.77% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 138. Cigna Corp's strong 12 month stock performance will appeal to momentum investors.

 yield
 value + yield
Shares currently yield 0.02%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cigna Corp ranks 267 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 8.2% 5 year annualized EPS growth, 12.5% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 12.8% speak to its impressive growth ranking.

Cigna Corp (CI)
Healthcare | Health Care Plans
CEO: David Michael Cordani
Employees: 39300
cigna.com


tickrz rank
A

VALUATION RATIOS
P/E Ratio21.2x
P/B Ratio2.9x
P/S Ratio1.03x
EV/EBITDA Ratio4.46x
DIVIDEND ANALYSIS
Dividend Yield0.02%
Payout RatioN/A
3 yr Dividend Growth0%
FINANCIAL STRENGTH
Piotroski F-ScoreNOT AVAILABLE
Debt-to-Equity32%
Interest Coverage0x
MOAT
ROE14.21%
ROIC0%
Net Margin4.7%
GROWTH
5 yr EPS Growth8.24%
5 yr SPS Growth12.54%
5 yr BPS Growth12.81%

TICKRZ RANK
Cigna Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cigna Corp's valuation score is comprised of a P/E ratio of 21.2x, a P/B ratio of 2.9x, a P/S ratio of 1x, and an EV/EBITDA ratio of 4.5x. Cigna Corp ranks 80 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Cigna Corp ranks 15 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cigna Corp warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
Interest coverage of 0x, a debt/equity ratio of 32% and a Moat Rank of 185 translate to an average Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 21.77% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 138. Cigna Corp's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.02%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cigna Corp ranks 267 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 8.2% 5 year annualized EPS growth, 12.5% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 12.8% speak to its impressive growth ranking.